Some reports show pasireotide reduced ACTH secretion and adenoma size in some patients with Nelson’s syndrome (54), but others show no response (55) or mixed response, with 5 patients in one series showing minimal impact on adenoma volume with pasireotide even though ACTH levels decreased (56). The gene discussed is POMC; the disease is adenoma.